AAAAAA

   
Results: 1-22 |
Results: 22
Karyometry of secretory cell nuclei in high-grade PIN lesions
Authors: Bartels, PH Montironi, RM Bostwick, D Marshall, J Thompson, D Bartels, HG Kelley, D
Citation: Ph. Bartels et al., Karyometry of secretory cell nuclei in high-grade PIN lesions, PROSTATE, 48(3), 2001, pp. 144-155
Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin
Authors: Xing, NZ Qian, JQ Bostwick, D Bergstralh, E Young, CYF
Citation: Nz. Xing et al., Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin, PROSTATE, 48(1), 2001, pp. 7-15
Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer - Overview consensus statement
Authors: Garnick, MB Fair, WR Bostwick, D Debruyne, F Fourcroy, J Grignon, D Porterfield, H Sufrin, G Thrasher, B Hart, C
Citation: Mb. Garnick et al., Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer - Overview consensus statement, MOL UROL, 4(3), 2000, pp. 89-92
Update on transrectal ultrasound-guided needle biopsy of the prostate - Open discussion following Dr. Cookson's presentation
Authors: Fair, W Cookson, MS Sakr, W Moul, J Garnick, M Stone, N Debruyne, F Bostwick, D
Citation: W. Fair et al., Update on transrectal ultrasound-guided needle biopsy of the prostate - Open discussion following Dr. Cookson's presentation, MOL UROL, 4(3), 2000, pp. 99-99
Epidemiology and molecular biology of early prostatic neoplasia - Open discussion following Dr. Sakr's presentation
Authors: Fair, W Bostwick, D Civantos, F Klotz, L Cookson, M Sakr, W Garnick, M Stone, N Grignon, D
Citation: W. Fair et al., Epidemiology and molecular biology of early prostatic neoplasia - Open discussion following Dr. Sakr's presentation, MOL UROL, 4(3), 2000, pp. 115-115
Significance of the Gleason scoring system after neoadjuvant hormonal therapy - Open discussion following Dr. Grignon's presentation
Authors: Garnick, M Grignon, DJ Klotz, L Fair, W Bostwick, D Stone, N Porterfield, H Garzotto, M Moul, J Bruchovsky, N Heston, W
Citation: M. Garnick et al., Significance of the Gleason scoring system after neoadjuvant hormonal therapy - Open discussion following Dr. Grignon's presentation, MOL UROL, 4(3), 2000, pp. 131-131
Effects of neoadjuvant hormonal therapy on prostate biopsy results after I-125 and Pd-103 seed implantation - Open discussion following Dr. Stone's presentation
Authors: Sylvester, J",Stone,"Bostwick, D Fair, W Garzotto, M Garnick, M Moul, J D'Amico, A
Citation: D. Sylvester, J",stone,"bostwick et al., Effects of neoadjuvant hormonal therapy on prostate biopsy results after I-125 and Pd-103 seed implantation - Open discussion following Dr. Stone's presentation, MOL UROL, 4(3), 2000, pp. 169-170
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer - Open discussionfollowing Dr. D'Amico's presentation
Authors: Grignon, D D'Amico, AV Zietman, A Moul, J Bostwick, D
Citation: D. Grignon et al., Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer - Open discussionfollowing Dr. D'Amico's presentation, MOL UROL, 4(3), 2000, pp. 177-177
High-intensity focused ultrasound: Complications and adverse events - Opendiscussion following Dr. Chaussy's presentations
Authors: Feleppa, E Chaussy, C Sufrin, G Bostwick, D
Citation: E. Feleppa et al., High-intensity focused ultrasound: Complications and adverse events - Opendiscussion following Dr. Chaussy's presentations, MOL UROL, 4(3), 2000, pp. 189-189
Combined androgen deprivation with radiotherapy for prostate cancer: Does it make sense? Open discussion following Dr. Zietman's and Dr. Garzotto's presentations
Authors: D'Amico, A Garzotto, M Bruchovsky, N Sufrin, G Zietman, AL Stone, N Grignon, D Civantos, F Bostwick, D Klotz, L
Citation: A. D'Amico et al., Combined androgen deprivation with radiotherapy for prostate cancer: Does it make sense? Open discussion following Dr. Zietman's and Dr. Garzotto's presentations, MOL UROL, 4(3), 2000, pp. 215-215
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy - Open discussion following Dr. Heston's presentation
Authors: Howell, S Heston, WDW Sakr, W Bostwick, D Bruchovsky, N Garnick, M Stone, N Garzotto, M
Citation: S. Howell et al., Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy - Open discussion following Dr. Heston's presentation, MOL UROL, 4(3), 2000, pp. 223-223
Comparative study of the clinical efficacy of two dosing regimens of flutamide - Open discussion following Dr. Thrasher's presentation
Authors: Bostwick, D",Thrasher,"Klotz, L Fourcroy, J Stone, N
Citation: L. Bostwick, D",thrasher,"klotz et al., Comparative study of the clinical efficacy of two dosing regimens of flutamide - Open discussion following Dr. Thrasher's presentation, MOL UROL, 4(3), 2000, pp. 265-265
Loss of expression of the DRR I gene at chromosomal segment 3p21.1 in renal cell carcinoma
Authors: Wang, L Darling, J Zhang, JS Liu, WG Qian, JQ Bostwick, D Hartmann, L Jenkins, R Bardenhauer, W Schutte, J Opalka, B Smith, DI
Citation: L. Wang et al., Loss of expression of the DRR I gene at chromosomal segment 3p21.1 in renal cell carcinoma, GENE CHROM, 27(1), 2000, pp. 1-10
Fifteen-year minimum follow-up of a prostate brachytherapy series: Comparing the past with the present
Authors: Schellhammer, PF Moriarty, R Bostwick, D Kuban, D
Citation: Pf. Schellhammer et al., Fifteen-year minimum follow-up of a prostate brachytherapy series: Comparing the past with the present, UROLOGY, 56(3), 2000, pp. 436-439
College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what? Summary document and recommendations for implementation
Authors: Hammond, MEH Fitzgibbons, PL Compton, CC Grignon, DJ Page, DL Fielding, LP Bostwick, D Pajak, T
Citation: Meh. Hammond et al., College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what? Summary document and recommendations for implementation, ARCH PATH L, 124(7), 2000, pp. 958-965
Histologic basis and optimal duration for neoadjuvant androgen deprivationtherapy - Discussion
Authors: Garnick, MB Civantos, F Bostwick, D Schulman, CC
Citation: Mb. Garnick et al., Histologic basis and optimal duration for neoadjuvant androgen deprivationtherapy - Discussion, MOL UROL, 2(3), 1998, pp. 101-101
Morphologic effects of neoadjuvant hormone therapy on prostate cancer - Discussion
Authors: Civantos, F Tetu, B Fair, WR Bostwick, D Trachtenberg, J Pienta, KJ Gleave, M
Citation: F. Civantos et al., Morphologic effects of neoadjuvant hormone therapy on prostate cancer - Discussion, MOL UROL, 2(3), 1998, pp. 109-109
Radical prostatectomy nu radical prostatectomy preceded by combined androgen blockade in clinical stage B-2 (T2bNxM0) prostate cancer: An update - Discussion
Authors: McLeod, D Civantos, F Schulman, CC Roach, M Grignon, D Fair, WR Bostwick, D Goldenberg, L Garnick, MB Trachtenberg, J
Citation: D. Mcleod et al., Radical prostatectomy nu radical prostatectomy preceded by combined androgen blockade in clinical stage B-2 (T2bNxM0) prostate cancer: An update - Discussion, MOL UROL, 2(3), 1998, pp. 163-164
Results of a European randomized study comparing radical prostatectomy andradical prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3NoMo prostatic carcinoma - Open discussion
Authors: Goldenberg, L Schulman, CC Fair, WR Gleave, M Garnick, MB Bostwick, D Grignon, D Rabbani, F
Citation: L. Goldenberg et al., Results of a European randomized study comparing radical prostatectomy andradical prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3NoMo prostatic carcinoma - Open discussion, MOL UROL, 2(3), 1998, pp. 187-187
Advanced two-dimensional and three-dimensional ultrasonic imaging of the prostate for detecting, evaluating, and monitoring cancer - Open discussion
Authors: Bostwick, D Feleppa, EJ Grignon, D Tractenberg, J Fair, WR Moul, J
Citation: D. Bostwick et al., Advanced two-dimensional and three-dimensional ultrasonic imaging of the prostate for detecting, evaluating, and monitoring cancer - Open discussion, MOL UROL, 2(3), 1998, pp. 237-237
Artificial neural networks applied to the diagnosis and prognosis of prostate cancer - Open discussion
Authors: Garnick, MB Snow, PB Trachtenberg, J Howell, S Bostwick, D
Citation: Mb. Garnick et al., Artificial neural networks applied to the diagnosis and prognosis of prostate cancer - Open discussion, MOL UROL, 2(3), 1998, pp. 245-245
Mechanisms of androgen resistance in prostate cancer - Open discussion
Authors: Fair, WR Pienta, KJ Trachtenberg, J Gleave, M Bostwick, D Garzotto, M Garnick, MB
Citation: Wr. Fair et al., Mechanisms of androgen resistance in prostate cancer - Open discussion, MOL UROL, 2(3), 1998, pp. 263-263
Risultati: 1-22 |